Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Study for Evaluating ESO-T01 Injection's Safety and Efficacy in Treating Relapsed/refractory Multiple Myeloma

NCT06791681 is registered in ClinicalTrials.gov with Chunrui Li as lead sponsor.

NCT NCT06791681
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06791681 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Study for Evaluating ESO-T01 Injection's Safety and Efficacy in Treating Relapsed/refractory Multiple Myeloma
Lead sponsor
Chunrui Li
Phase
Phase 1
Overall status
Recruiting
Start date
January 27, 2025
Completion date
November 30, 2027
Enrollment
24 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

relapsed/ refractory multiple myeloma